The global veterinary infectious disease diagnostics market is estimated to reach a valuation of US$ 1.9 billion in 2023. As per Future Market Insights (FMI) analysis, the veterinary infectious disease diagnostics market size is expected to surpass US$ 4.9 billion in the next decade. Between 2023 and 2033, the market has been forecast to register a 10.1% CAGR.
Global Trends & Scopes Transforming the Veterinary Infectious Disease Diagnostics Market
With diagnostic innovation, key players are devoted to providing a better experience for customers. Veterinarians may reliably obtain full diagnostic insights anytime, anywhere, thanks to artificial intelligence (AI) algorithms that provide cost-effective access to expert-level results, remote veterinary specialist evaluation, and post-diagnostic consultations.
Their unique product and service combination provides a full picture, allowing veterinarians to make faster, more educated medical decisions for more tailored treatment. They see their veterinarian clients as partners in their goal. As a result, they are keen to customize their services to the demands of the end user, tailoring their solutions to fit inside – and improve – their existing protocols.
The veterinary microbiology solutions given by key companies are designed with veterinary labs in mind and comprise a full variety of high-quality culture mediums, identification, and susceptibility testing items. It also has automated Johne's Disease instruments and reagents.
They collaborate with veterinarians, farmers, and pet owners regularly to create safe, effective, and practical solutions that improve treatment adherence. They cover the bulk of therapeutic segments and care for practically all species treated by veterinary medicine, including thousands of pharmacological, biological, nutritional, and diagnostic items.
Their multinational presence enables them to address concerns that are specific to each country. They accomplish this by offering products and services that satisfy the demands of all people who care for animals all around the world daily.
Key players are exploring novel solutions for more responsible reproduction management that respects the animal's well-being of companion animals, as well as food-producing animals.
Most of the diagnostics given by significant providers are ISO 17025 certified, including testing on PCR and ELISA platforms. Their comprehensive offerings provide industry-leading knowledge to end users. This comprises high-quality, low-cost diagnostic and surveillance testing options, as well as quick response times, frequently within 24 hours. Their diagnostic solutions and services meet the demands of the end-user and guarantee that they receive the data they require to reduce risks and protect the health and safety of their pet.
For reliable pathogen and bacterial testing in molecular laboratories, standardization and automation are required. Automated processing improves repeatability, reduces human error, and produces reliable results.
As a result, prominent players' integrated systems employ pathogen and viral load assays. These strategies aid in increasing efficiency and optimizing processes. Furthermore, their leading automated systems provide the flexibility and scalability required by labs to react to changing testing demands.
| Attributes | Details |
|---|---|
| Veterinary Infectious Disease Diagnostics Market CAGR (2017 to 2022) | 11.9% |
| Veterinary Infectious Disease Diagnostics Market CAGR (2023 to 2033) | 10.1% |
| Market Size for Veterinary Infectious Disease Diagnostics (2023) | US$ 1.9 billion |
| Market Size forVeterinary Infectious Disease Diagnostics (2033) | US$4.9billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to a Future Market Insights analysis, the global market for veterinary infectious disease diagnostics has lately expanded dramatically. Top competitors in the industry are collaborating to fulfill increased demand for veterinary infectious disease diagnostics. The estimated CAGR, which was 11.9% from 2017 to 2022, is expected to fall to 10.1%.
Over the last few years, there has been a rapid surge in pet adoption, especially across developed and developing countries like the USA France, China, Germany, India, etc. This is acting as a catalyst for the growth of the veterinary infectious disease diagnostics market, and the trend is likely to follow during the forecast period.
Similarly, rising concerns regarding the spread of infectious diseases from animals to humans are providing an impetus to the growth of the veterinary infectious disease diagnostic market. According to the Centers for Disease Control and Prevention (CDC), scientists have estimated that around more than 6 out of every 10 known infectious diseases in people can be spread by animals.
Sales of rapid diagnostic tests for infectious diseases are mostly rising across developed countries due to increasing pet adoption and the flourishing animal healthcare market. However, demand for veterinary diagnostics is expected to grow at a substantial pace in emerging economies during the forecast period, owing to the increasing pet adoption, favorable government support, and increasing farm animal population.
Subsequently, the rapid expansion of veterinary hospitals and veterinary clinics, coupled with an increase in the number of veterinary practitioners and animal diseases diagnostic laboratories, is likely to further boost the growth of the veterinary infectious disease diagnostics market during the forthcoming years.
The expansion of the infectious animal diseases market size and burgeoning demand for veterinary diagnostics may create lucrative opportunities-leading market players in the future.
Sales of immunodiagnostics remain high in the global veterinary infectious disease diagnostics market.
Based on technology, the immunodiagnostics segment leads the global veterinary infectious disease diagnostics market in 2022 and is forecast to grow at a robust CAGR over the assessment period. Growing end-user preference for immunodiagnostics technology due to its various advantages is a key factor triggering the growth of this segment.
The increasing prevalence of animal diseases, coupled with rising immunodiagnostics sales, is anticipated to provide lucrative opportunities for market players during the forecast period.
Demand for Veterinary Infectious Disease Diagnostics Remains High in Companion Animal Category
Based on animal type, the companion animal segment is likely to grow at a relatively higher CAGR over the forecast period, owing to the rising pet adoption across developed and developing regions, increasing penetration of pet insurance, and increasing need for early detection and treatment of animal disease to eliminate the risk of disease spread.
Moreover, the expansion of markets like the pet care market and companion animals vaccines market is also favoring the growth of this segment.
Principal Consultant
Reference Laboratories to Remain Ideal Destinations for Veterinary Infectious Disease Diagnostics
Based on end users, the veterinary reference laboratories segment accounts for the leading revenue share in the global veterinary infectious disease diagnostics market. This is attributable to the increase in the number of veterinary practitioners, growing pet adoption rates, and the rapid expansion of the veterinary reference laboratory market.
Increased Adoption of Companion Animals fueling Growth Prospects
On a global basis, an increase in the total number of companion animals and their rate of adoption has been noted. Numerous studies have found links between pet ownership and good health, including the normalization of blood pressure, fewer cardiac arrhythmias, increased psychological stabilization, reduced anxiety, and enhanced well-being.
The demand for pet care goods and services is anticipated to rise in response to the rising pet population, which is likely to in turn fuel the expansion of related sectors, such as the veterinary infectious disease diagnostics market globally.
For example, in North America, a pet was owned by 68% of US homes or around 84.9 million families, as per the American Pet Products Association's (APPA) National Pet Owners Survey (2020–2021). Also, 43 million families had cats, 64 million had dogs, and 1.7 billion had all three. Thus, with such skyrocketing demand for pets, the need for veterinary infectious diseases diagnostics is expected to be growing rapidly too.
Despite its optimistic stance, the global veterinary infectious diseases diagnostics market is facing various obstacles that are challenging its growth. Some of these obstacles are the increasing cost of veterinary treatment, poor availability of advanced veterinary disease diagnostic laboratories across low economies, and lack of pet insurance policies in some regions.
| Country | United States |
|---|---|
| CAGR (2023 to 2033) | 9.8% |
| CAGR (2017 to 2022) | 14% |
| Country | United Kingdom |
|---|---|
| CAGR (2023 to 2033) | 9.1% |
| CAGR (2017 to 2022) | 13% |
| Country | Japan |
|---|---|
| CAGR (2023 to 2033) | 9.4% |
| CAGR (2017 to 2022) | 13.6% |
| Country | South Korea |
|---|---|
| CAGR (2023 to 2033) | 8.5% |
| CAGR (2017 to 2022) | 12.5% |
| Country | Australia |
|---|---|
| CAGR (2023 to 2033) | 8.1% |
| CAGR (2017 to 2022) | 11.4% |
| Attributes | Details |
|---|---|
| US Market Size (2033) | US$1.7 billion |
| US Market Absolute Dollar Growth (US$ Million/Billion) | US$ 3 billion |
The veterinary infectious disease diagnostics market is dominated by the United States, which accounts for 9.8% of total North American sales. The veterinary infectious disease diagnostics market in the United States is expected to reach a peak of US$ 1.7 billion.
The region's veterinary healthcare expenditure has increased significantly, which is likely to fuel market growth. Furthermore, the availability of healthcare programs and an increase in the number of efforts to enhance animal health are elements that are expected to increase the region's growth potential.
The purpose of veterinary diagnostics in the United States is to create ways to battle animal infections and zoonoses, while also helping the sensible use of antibiotics in veterinary medicine. Time-to-diagnosis and treatment accuracy are critical components of case management, as are infection control, the battle against multi-drug resistance, and the reduction of animal healthcare expenditures.
Key players provide a full variety of animal health solutions based on manual or automated technologies, from sample to decision. Market participants provide a diverse range of ELISA and RIA kits for veterinary diagnostics. Their principal products include salivary diagnostics, as well as assays for viral illnesses, autoimmunity, biogenic amines, and tumor markers.
They work to enhance the health and comfort of dogs suffering from neurologic illness. This is accomplished by combining the art of compassionate care with the science of veterinary neurology.
The relevance of animal health bioanalysis is recognized by key players. Key players are happy to support the creative work being done, from improving therapeutic capacities for precious pets to ensuring the food they ingest is safe.
With innovative solutions in pet diagnostics in the country, pet owners can be certain that their analytic requirements are met with the utmost care and attention.
| Attributes | Details |
|---|---|
| United Kingdom Market Size (2033) | US$ 206.2 million |
| United Kingdom Market Absolute Dollar Growth (US$ Million/Billion) | US$ 120 million |
The United Kingdom is a substantial veterinary infectious disease diagnostics market, with an expected value of US$ 206.2 million and a revenue growth rate of 9.1% during the forecast period. Key stakeholders in helping pet owners hope to better educate them by providing a variety of materials. These enable pet owners to make educated decisions about their pet's health. Moreover, their website is meant to be an intriguing and educational veterinary health reference.
The research and development operations of key players in the United Kingdom guarantee that their products represent cutting-edge RT-PCR and ELISA technology. Furthermore, they guarantee that the goods enable them to constantly launch fresh, inventive experiments.
To stay ahead of the curve in infectious disease diagnostics, they reinvest 30% of their revenue in research and development initiatives, collaborate with premier experts and reference laboratories throughout the world, and engage in European research programs.
The primary focus of research centers is to provide creative solutions, tests, samples, and so on for veterinary needs. For instance, the University of Glasgow's Veterinary Diagnostic Services department is dedicated to processing all data clearly and transparently, as well as securely keeping and disposing of all data following GDPR rules.
On request, they can provide complimentary swabs, viral transfer medium, submission forms, and prepaid postal labels. In addition, laboratory findings are confirmed by veterinary consultants before being communicated to the submitting veterinarian practice.
| Attributes | Details |
|---|---|
| Japan Market Size (2033) | US$ 351.6 million |
| Japan Market Absolute Dollar Growth (US$ Million/Billion) | US$ 208.9 million |
Japan accounts for 9.4% of overall revenues in the veterinary infectious disease diagnostics market. The Japanese veterinary infectious disease diagnostics market is worth US$ 351.6 million. This is attributed to the increasing acceptability of companion animals. Additionally, there is a significant need for animal proteins in the country, which is projected to drive regional market expansion.
Key players in Japan concentrate on a wide spectrum of bacterial and parasite illnesses of domestic animals, including zoonosis. Moreover, biosensor technologies are being tested for use in determining the health condition of individual animals.
Key players in Japan are providing diagnostic services employing new technology to diagnose novel illnesses, especially exotic diseases, to enhance animal health. This is done in response to requests from Japan's national and municipal governments.
| Attributes | Details |
|---|---|
| Australia Market Size (2033) | US$174.1million |
| Australia Market Absolute Dollar Growth (US$ Million/Billion | US$ 94.1 million |
Australia is a very profitable veterinary infectious disease diagnostics market, with a revenue growth rate of 8.1% and a projected value of US$ 174.1 million during the projection year. Key players and research institutions in the country are investigating methods to improve the welfare of pets and livestock. They accomplish this by establishing scientific tools for analyzing how animals' feelings are affected by standard management practices.
Key players in the country supply animals with complicated illnesses with inexpensive, world-class medical, surgical, and emergency care. For instance, one market participant collaborates with both pet owners and veterinarians to give treatment at vet clinics around Greater Sydney via their mobile service. They claim to collaborate with veterinarians to give the best possible care for the owner's pet.
Many animal problems are detected, diagnosed, and solved by Australian market players in collaboration with veterinarians and animal health officials. Furthermore, they collaborate with primary farmers and industry to find creative solutions to issues. Certain key players, for instance, have employed a 3D scanner to get an accurate image of a horse's Laminitis-affected hoof. They then successfully tailored a 3D-printed shoe to support and heal the hoof.
With an aging pet population and accompanying age-related disorders, there are few novel and natural therapies to assist in giving treatment for problems like osteoarthritis. As a result, important manufacturers discovered a market gap for natural plant-derived animal medicines that are both safe and effective. This is done largely to promote greater health and well-being for companion animals, with a concentration on cannabis-derived chemicals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Start-up companies are offering veterinary solutions that are incorporated with artificial intelligence (AI), which is contributing to the global veterinary infectious disease diagnostics market growth:
Due to the presence of multiple established competitors, the veterinary infectious disease diagnostics market share is very competitive. To capitalize on market growth potential, these firms are focusing on increasing their reach through acquisitions, expansions, product approvals, and launches.
Recent Developments:
Rising pet adoption rates, more attention to animal health, and improvements in diagnostic technology.
Point-of-care testing and the incorporation of molecular methods.
The United States is expected to register a CAGR of 9.8% through 2033.
Immunodiagnostics remain prominent due do the increasing prevalence of animal diseases.
The market recorded a CAGR of 11.9% from 2018 to 2022.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 5.3.1. Immunodiagnostics 5.3.2. Molecular Diagnostic 5.3.3. Others 5.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Animal Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033 6.3.1. Companion Animals 6.3.2. Food-producing Animals 6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Reference Laboratories 7.3.2. Veterinary Hospitals and Clinics 7.3.3. Point of Care 7.3.4. Research Institutes & Universities 7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Technology 9.2.3. By Animal Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Technology 9.3.3. By Animal Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Technology 10.2.3. By Animal Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Technology 10.3.3. By Animal Type 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Technology 11.2.3. By Animal Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technology 11.3.3. By Animal Type 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Thailand 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. Rest of Asia Pacific 12.2.2. By Technology 12.2.3. By Animal Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technology 12.3.3. By Animal Type 12.3.4. By End User 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Technology 13.2.3. By Animal Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technology 13.3.3. By Animal Type 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Technology 14.1.2.2. By Animal Type 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Technology 14.2.2.2. By Animal Type 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Technology 14.3.2.2. By Animal Type 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Technology 14.4.2.2. By Animal Type 14.4.2.3. By End User 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Technology 14.5.2.2. By Animal Type 14.5.2.3. By End User 14.6. United kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Technology 14.6.2.2. By Animal Type 14.6.2.3. By End User 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Technology 14.7.2.2. By Animal Type 14.7.2.3. By End User 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Technology 14.8.2.2. By Animal Type 14.8.2.3. By End User 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Technology 14.9.2.2. By Animal Type 14.9.2.3. By End User 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Technology 14.10.2.2. By Animal Type 14.10.2.3. By End User 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Technology 14.11.2.2. By Animal Type 14.11.2.3. By End User 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Technology 14.12.2.2. By Animal Type 14.12.2.3. By End User 14.13. Thailand 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Technology 14.13.2.2. By Animal Type 14.13.2.3. By End User 14.14. Singapore 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Technology 14.14.2.2. By Animal Type 14.14.2.3. By End User 14.15. Australia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Technology 14.15.2.2. By Animal Type 14.15.2.3. By End User 14.16. GCC Countries 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Technology 14.16.2.2. By Animal Type 14.16.2.3. By End User 14.17. South Africa 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Technology 14.17.2.2. By Animal Type 14.17.2.3. By End User 14.18. Israel 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Technology 14.18.2.2. By Animal Type 14.18.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Technology 15.3.3. By Animal Type 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. IDEXX Laboratories, Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Zoetis, Inc. 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Thermo Fisher Scientific 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Virbac 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Biomerieux SA 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Heska Corporation 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. IDvet 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. NEOGEN Corporation 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. QIAGEN N.V. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Randox Laboratories Ltd. 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Veterinary Infectious Disease Diagnostics Market
